Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.

Kim C, Bi X, Pan D, Chen Y, Carling T, Ma S, Udelsman R, Zhang Y.

Thyroid. 2013 May;23(5):575-82. doi: 10.1089/thy.2011.0406. Epub 2013 Apr 18.

2.

Second primaries after major salivary gland cancer.

Megwalu UC, Shin EJ.

Otolaryngol Head Neck Surg. 2011 Aug;145(2):254-8. doi: 10.1177/0194599811402899.

PMID:
21493280
3.

Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.

Marti JL, Jain KS, Morris LG.

Thyroid. 2015 Jun;25(6):681-7. doi: 10.1089/thy.2015.0067. Epub 2015 May 6.

4.

Italian cancer figures, report 2013: Multiple tumours.

AIRTUM Working Group.

Epidemiol Prev. 2013 Jul-Oct;37(4-5 Suppl 1):1-152. English, Italian.

5.

Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.

Cho YY, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.

Cancer. 2015 Jan 15;121(2):259-68. doi: 10.1002/cncr.29025. Epub 2014 Sep 15.

6.

Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.

Spanogle JP, Clarke CA, Aroner S, Swetter SM.

J Am Acad Dermatol. 2010 May;62(5):757-67. doi: 10.1016/j.jaad.2009.07.039. Epub 2010 Mar 12.

PMID:
20223559
7.

Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.

Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF.

Ann Surg Oncol. 2012 Jun;19(6):1887-96. doi: 10.1245/s10434-011-2193-2. Epub 2012 Jan 7.

8.

Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.

Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, Liu CJ.

J Natl Cancer Inst. 2015 Nov 3;108(2). pii: djv314. doi: 10.1093/jnci/djv314. Print 2016 Feb.

PMID:
26538627
9.

Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.

Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF.

Cancer Lett. 2006 Jul 8;238(1):42-52. Epub 2005 Jul 21.

PMID:
16039041
10.
11.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.

Arch Dermatol. 2007 Jan;143(1):45-50.

PMID:
17224541
12.

Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.

Werner-Wasik M, Schmid CH, Bornstein LE, Madoc-Jones H.

Cancer. 1995 May 1;75(9):2281-5.

13.

Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries.

Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E.

Lancet Oncol. 2011 Apr;12(4):353-60. doi: 10.1016/S1470-2045(11)70061-4.

14.

Thyroid cancer and multiple primary tumors in the SEER cancer registries.

Ronckers CM, McCarron P, Ron E.

Int J Cancer. 2005 Nov 1;117(2):281-8.

15.

Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.

Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fosså SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB.

J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43. Epub 2007 Oct 30.

16.

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.

Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I.

Cancer. 2011 Oct 1;117(19):4439-46. doi: 10.1002/cncr.26070. Epub 2011 Mar 22.

17.

The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.

Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD.

J Clin Endocrinol Metab. 2008 Feb;93(2):504-15. Epub 2007 Nov 20.

PMID:
18029468
18.

Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma.

Huang J, Walker R, Groome PG, Shelley W, Mackillop WJ.

Cancer. 2001 Sep 15;92(6):1411-8.

PMID:
11745217
19.

The development of breast carcinoma in women with thyroid carcinoma.

Chen AY, Levy L, Goepfert H, Brown BW, Spitz MR, Vassilopoulou-Sellin R.

Cancer. 2001 Jul 15;92(2):225-31.

PMID:
11466673
20.

Second primary cancers in thyroid cancer patients: a multinational record linkage study.

Sandeep TC, Strachan MW, Reynolds RM, Brewster DH, Scélo G, Pukkala E, Hemminki K, Anderson A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kirn V, Kliewer EV, Tonita JM, Jonasson JG, Martos C, Boffetta P, Brennan P.

J Clin Endocrinol Metab. 2006 May;91(5):1819-25. Epub 2006 Feb 14.

PMID:
16478820
Items per page

Supplemental Content

Write to the Help Desk